$1.6bn Bharat Serums Buy Gives Mankind Dominance In Women's Health, R&D Engine

PE Firm Advent Exits At 22-23x FY25 EBITDA

 
• By Vibha Ravi
  
Building Growth Through Acquisitions
Acquisitions Have Been Part Of Mankind's Growth Strategy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip